Vivek K Gupta Selected Research

Hexokinase

11/2013

Light activation of the insulin receptor regulates mitochondrial hexokinase. A possible mechanism of retinal neuroprotection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivek K Gupta Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 10/2013
7	Glaucoma 12/2021 - 04/2014
3	Ganglion Cysts (Ganglion) 09/2020 - 01/2013
3	Tuberculosis (Tuberculoses) 05/2017 - 12/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 10/2017
2	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 10/2013
1	Hemorrhage 04/2022
1	Ischemia 04/2022
1	Cardiogenic Shock 04/2022
1	Infections 01/2022
1	Multiple Sclerosis 12/2021
1	Stroke (Strokes) 12/2021
1	Parkinson Disease (Parkinson's Disease) 12/2021
1	COVID-19 01/2021
1	Gliosis 10/2020
1	Disease Progression 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2020
1	Neoplasms (Cancer) 05/2020
1	Foreign Bodies (Foreign Body) 01/2020
1	Granuloma 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019
1	Circulating Neoplastic Cells 02/2018
1	Inflammation (Inflammations) 10/2017
1	Demyelinating Diseases (Demyelinating Disease) 07/2015
1	type 2 Amaurosis congenita of Leber 11/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2013
1	Breast Neoplasms (Breast Cancer) 12/2009
1	Airway Obstruction (Choking) 01/2004
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2004

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2017
3	Amyloid (Amyloid Fibrils)IBA 09/2019 - 01/2016
2	AntioxidantsIBA 05/2020 - 05/2017
2	ProteomeIBA 10/2017 - 01/2017
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	Inosine Monophosphate (IMP)IBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 12/2021
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021
1	CaveolinsIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Amyloid beta-PeptidesIBA 11/2020
1	Glatiramer Acetate (Copaxone)FDA Link 10/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2020
1	Caveolin 1IBA 09/2020
1	Caspase 3 (Caspase-3)IBA 09/2020
1	Glutathione (Reduced Glutathione)IBA 07/2020
1	Carrier Proteins (Binding Protein)IBA 07/2020
1	Crystallins (Crystallin)IBA 07/2020
1	CholesterolIBA 07/2020
1	SiliconesIBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Polysaccharides (Glycans)IBA 02/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2014
1	Hematoxylin (Haematoxylon)IBA 04/2014
1	SilverIBA 04/2014
1	Neuroprotective AgentsIBA 04/2014
1	HexokinaseIBA 11/2013
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 10/2013
1	6,7-dihydroxyflavoneIBA 01/2013
1	Volatile Oils (Essential Oils)IBA 12/2012
1	HexanesIBA 12/2012
1	Biological ProductsIBA 12/2009
1	Capsules (Microcapsules)IBA 12/2009
1	PolyelectrolytesIBA 12/2009

Therapy/Procedure

3	Microspheres (Microsphere) 01/2021 - 10/2013
2	Injections 01/2021 - 07/2020
2	Therapeutics 10/2020 - 07/2015
1	Extracorporeal Membrane Oxygenation 04/2022
1	Length of Stay 04/2022
1	Blood Transfusion (Blood Transfusions) 04/2022
1	Immunomodulation 10/2020
1	Immunotherapy 10/2020
1	Intracameral Injection 10/2013
1	Operative Surgical Procedures 01/2004
1	Airway Management 01/2004